U.S. Vaccine Schedule Overhaul Sparks Measles Surge and Legal Backlash

Key points

• HHS Secretary RFK Jr. fired all 17 members of the Advisory Committee on Immunization Practices (ACIP) in 2025, citing alleged conflicts of interest that were later debunked as paperwork errors.
• The new ACIP voted to remove thimerosal from flu vaccines based on a presentation citing a study that does not exist, and ended the universal recommendation for newborn hepatitis B vaccines.
• Measles cases in the U.S. reached 3,134 by September 2026, the highest in over 35 years, with three deaths in 2025 and potential new deaths in 2026.
• The American Academy of Pediatrics sued HHS, and a federal judge issued a preliminary injunction in March 2026, halting the new committee's votes pending appeal.
• The administration's 'Gold Standard' executive order recommends splitting MMR shots, despite no licensed single-disease vaccines existing in the U.S., and cites international comparisons that experts say are epidemiologically flawed.

Background

This development follows a series of policy shifts in 2026, including RFK Jr.'s use of the Children's Health Defense platform to promote vaccine skepticism and the nomination of Dr. Nicole Saphier as surgeon general, who defended vaccines against autism claims. Earlier in 2026, Congress saw debates over vaccine policy and AI safeguards, with HHS facing scrutiny over its approach to public health data and vaccine schedules. The current changes build on a pattern of indirect policy maneuvers aimed at reshaping vaccine recommendations, as noted in prior coverage of HHS's strategy to influence committee charters and litigation.

How outlets are covering it

Skeptic Magazine emphasizes the scientific consensus against vaccine-autism links, highlighting the fraudulent nature of Andrew Wakefield's 1998 study and the subsequent debunking by large-scale studies. It criticizes the administration's reliance on nonexistent studies and flawed international comparisons, arguing that the U.S. is now an outlier in vaccine coverage. NAM frames the issue through an economic lens, stating that low vaccination rates reduce manufacturing productivity and cost employers billions, urging HHS to preserve the science-based framework. The Herald Bulletin, via Dr. Richard Feldman, warns that the changes will bring disaster, aligning with medical experts who view the policy shifts as harmful and scientifically unsound. All sources agree on the negative impact of the changes but differ in emphasis: Skeptic focuses on scientific integrity, NAM on economic costs, and the Herald Bulletin on public health risks.

Why it matters

The changes to the U.S. vaccine schedule have direct implications for public health, with rising measles cases and potential increases in other preventable diseases. The legal challenges and executive orders signal a broader conflict between scientific consensus and political influence in health policy. Economically, low vaccination rates could lead to increased absenteeism and productivity losses, as noted by NAM. The situation also raises concerns about the integrity of federal health agencies and the role of evidence-based policy in public health decisions.

What to watch

HHS has appealed the federal judge's preliminary injunction halting the new ACIP's votes. The administration is expected to continue pushing its 'Gold Standard' guidelines, while medical organizations and legal challenges may escalate. Public health outcomes, including measles case counts and hepatitis B infection rates, will be closely monitored in the coming months. The administration's response to the legal and scientific pushback will determine the long-term impact of these policy changes.